MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVED FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
Miguel Regueiro 1
Mingyang Shan 2
Paul Pollack 2
Lai Shan Chan 2
Pieter Hindryckx 3
Theresa Hunter Gibble 2
Monika Fischer 4
David T. Rubin
Deanilee Deckard
1 Cleveland Clinic Main Campus,Cleveland,United States
2 Eli Lilly and Company,Indianapolis,United States
3 Hospital of Ghent,Ghent,Belgium
4 Indiana University,Indianapolis,United States
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]